RO81943B - Procedeu de preparare a unor derivati de piridoxina - Google Patents
Procedeu de preparare a unor derivati de piridoxinaInfo
- Publication number
- RO81943B RO81943B RO104319A RO10431981A RO81943B RO 81943 B RO81943 B RO 81943B RO 104319 A RO104319 A RO 104319A RO 10431981 A RO10431981 A RO 10431981A RO 81943 B RO81943 B RO 81943B
- Authority
- RO
- Romania
- Prior art keywords
- preparation
- methyl
- derivatives
- general formula
- piridoxine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Inventia prezinta un procedeu de preparare a unor derivati de piridoxina cu formula generala I: (vezi formula) în care R reprezinta un radical (vezi formula) în care n este 1, X si X1 sunt diferiti si reprezinta hidrogen sau metil si R1 reprezinta o grupa fenil sau fenil mono sau disubstituit cu fluor, clor, brom, metil, etil, n-propil, izopropil si metoxi, constînd din aceea ca 3-0-(2,3-epoxipropil)-alfa, alfa-izopropilidenpiridoxolul cu formula II: (vezi formula) se trateaza la reflux si în metanol ca solvent, cu o amina cu formula generala III: (vezi formula) în care R are semnificatiile de mai sus, pentru a obtine un cetal care apoi este hidrolizat în mediu puternic acid, la o temperatura cuprinsa între 25 si 80 degree C pentru a obtine derivatul de piridoxina I sub forma de baza libera, care, eventual, poate fi transformat prin tratare cu un acid organic sau anorganic adecvat în sarea de aditie netoxica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8016516 | 1980-05-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RO81943B true RO81943B (ro) | 1983-05-30 |
| RO81943A RO81943A (ro) | 1983-06-01 |
Family
ID=10513518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RO81104319A RO81943A (ro) | 1980-05-19 | 1981-05-18 | Procedeu de preparare a unor derivati de piridoxina |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US4374841A (ro) |
| EP (1) | EP0040591B1 (ro) |
| JP (1) | JPS5711966A (ro) |
| AR (1) | AR226356A1 (ro) |
| AT (1) | ATE3859T1 (ro) |
| AU (1) | AU542463B2 (ro) |
| BG (1) | BG35327A3 (ro) |
| CA (1) | CA1152080A (ro) |
| CS (1) | CS223842B2 (ro) |
| DD (1) | DD159071A5 (ro) |
| DE (1) | DE3160480D1 (ro) |
| DK (1) | DK217481A (ro) |
| EG (1) | EG15890A (ro) |
| ES (1) | ES8203845A1 (ro) |
| FI (1) | FI811525A7 (ro) |
| GR (1) | GR82343B (ro) |
| HU (1) | HU183441B (ro) |
| IE (1) | IE51179B1 (ro) |
| IL (1) | IL62602A (ro) |
| IN (1) | IN151915B (ro) |
| IS (1) | IS1183B6 (ro) |
| MA (1) | MA19147A1 (ro) |
| NO (1) | NO811680L (ro) |
| NZ (1) | NZ196766A (ro) |
| OA (1) | OA06811A (ro) |
| PL (1) | PL129213B1 (ro) |
| PT (1) | PT72992B (ro) |
| RO (1) | RO81943A (ro) |
| SU (1) | SU1077566A3 (ro) |
| YU (1) | YU126281A (ro) |
| ZA (1) | ZA812448B (ro) |
| ZW (1) | ZW9681A1 (ro) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663354A (en) * | 1984-04-26 | 1987-05-05 | Klinge Pharma Gmbh | Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia |
| DE3519693A1 (de) * | 1985-06-01 | 1987-01-02 | Basf Ag | Pyridin-derivate, ihre herstellung und verwendung |
| US6051587A (en) * | 1998-04-16 | 2000-04-18 | Medicure, Inc. | Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
| US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
| BR0008857A (pt) | 1999-03-08 | 2001-12-18 | Medicure Inc | Análogos de piridoxal para distúrbios da vitaminab-6 |
| CA2376029A1 (en) * | 1999-07-13 | 2001-01-18 | Medicure Inc. | Use of pyridoxin derivatives for the treatment of diabetes and related complications |
| US6677356B1 (en) * | 1999-08-24 | 2004-01-13 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
| WO2001064692A1 (en) | 2000-02-29 | 2001-09-07 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| AU784840B2 (en) | 2000-03-28 | 2006-07-06 | Medicure International Inc. | Treatment of cerebrovascular disease |
| US6897228B2 (en) * | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
| US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
| US6417204B1 (en) | 2000-07-07 | 2002-07-09 | Medicure International Inc. | Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics |
| US20040121988A1 (en) * | 2001-03-28 | 2004-06-24 | Medicure International Inc. | Treatment of cerebrovascular disease |
| JP4048166B2 (ja) * | 2002-11-18 | 2008-02-13 | 三井製糖株式会社 | 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料 |
| US20040186077A1 (en) * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents |
| JP2006521349A (ja) * | 2003-03-27 | 2006-09-21 | メディキュア インコーポレーテッド | 狭心症を治療するための組成物 |
| AU2005259735A1 (en) * | 2004-07-07 | 2006-01-12 | Medicure International Inc. | Combination therapies employing platelet aggregation drugs |
| US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
| US7459468B2 (en) * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
| US20060094749A1 (en) * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents |
| WO2006050598A1 (en) * | 2004-10-28 | 2006-05-18 | Medicure International Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
| JP2009517411A (ja) * | 2005-11-28 | 2009-04-30 | メディキュア インターナショナル インコーポレーテッド | 心血管及び関連病状の処置のための調剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR208397A1 (es) * | 1973-02-20 | 1976-12-27 | Ciba Geigy Ag | Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan |
| US4115575A (en) * | 1973-02-20 | 1978-09-19 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)-pyrazines |
| GB1485919A (en) * | 1975-08-12 | 1977-09-14 | Grindstedvaerket As | Pyridine derivatives |
| DE2711655A1 (de) * | 1977-03-17 | 1978-09-21 | Basf Ag | Pyridinyl-aminoalkylaether |
| US4210653A (en) * | 1978-06-27 | 1980-07-01 | Merck & Co., Inc. | Pyridyloxypropanolamines |
-
1981
- 1981-04-07 IL IL62602A patent/IL62602A/xx unknown
- 1981-04-08 NZ NZ196766A patent/NZ196766A/en unknown
- 1981-04-10 IS IS2631A patent/IS1183B6/is unknown
- 1981-04-13 ZA ZA00812448A patent/ZA812448B/xx unknown
- 1981-04-14 GR GR64686A patent/GR82343B/el unknown
- 1981-04-27 ZW ZW96/81A patent/ZW9681A1/xx unknown
- 1981-04-28 BG BG051875A patent/BG35327A3/xx unknown
- 1981-05-02 IN IN465/CAL/81A patent/IN151915B/en unknown
- 1981-05-07 PT PT72992A patent/PT72992B/pt unknown
- 1981-05-07 AR AR285225A patent/AR226356A1/es active
- 1981-05-11 US US06/262,449 patent/US4374841A/en not_active Expired - Fee Related
- 1981-05-12 EG EG260/81A patent/EG15890A/xx active
- 1981-05-13 AU AU70535/81A patent/AU542463B2/en not_active Ceased
- 1981-05-13 MA MA19356A patent/MA19147A1/fr unknown
- 1981-05-15 IE IE1085/81A patent/IE51179B1/en unknown
- 1981-05-15 JP JP7407681A patent/JPS5711966A/ja active Pending
- 1981-05-15 PL PL1981231193A patent/PL129213B1/pl unknown
- 1981-05-15 YU YU01262/81A patent/YU126281A/xx unknown
- 1981-05-15 CS CS813634A patent/CS223842B2/cs unknown
- 1981-05-15 CA CA000377739A patent/CA1152080A/en not_active Expired
- 1981-05-15 DE DE8181870023T patent/DE3160480D1/de not_active Expired
- 1981-05-15 EP EP81870023A patent/EP0040591B1/fr not_active Expired
- 1981-05-15 AT AT81870023T patent/ATE3859T1/de not_active IP Right Cessation
- 1981-05-18 SU SU813289800A patent/SU1077566A3/ru active
- 1981-05-18 OA OA57404A patent/OA06811A/xx unknown
- 1981-05-18 ES ES502276A patent/ES8203845A1/es not_active Expired
- 1981-05-18 RO RO81104319A patent/RO81943A/ro unknown
- 1981-05-18 NO NO811680A patent/NO811680L/no unknown
- 1981-05-18 DK DK217481A patent/DK217481A/da not_active Application Discontinuation
- 1981-05-18 DD DD81230039A patent/DD159071A5/de unknown
- 1981-05-18 FI FI811525A patent/FI811525A7/fi not_active Application Discontinuation
- 1981-05-18 HU HU811402A patent/HU183441B/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RO81943B (ro) | Procedeu de preparare a unor derivati de piridoxina | |
| DK0944617T3 (da) | Krystaller af benzimidazolderivater og deres fremstilling | |
| ES8506612A1 (es) | Un metodo para producir un derivado de amina | |
| ES2000910A6 (es) | Procedimiento para preparar piridina-2,3-dicarboxilatos sustituidos y disustituidos | |
| ES8603497A1 (es) | Procedimiento para preparar derivados de cefalosporina | |
| ES8607912A1 (es) | Un derivado de fenilserina | |
| ATE10838T1 (de) | 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung. | |
| GB855719A (en) | Process for the production of 4-nitro-diarylamines | |
| FI892327A0 (fi) | Foerfarande foer framstaellning av cykliska sulfat. | |
| GB977071A (en) | Hydroxylamine derivatives and process for making them | |
| ATE3405T1 (de) | Verfahren zur herstellung von 4-phenoxyphenolen. | |
| ATE30718T1 (de) | Herstellung von 1-benzyl azetidin-3-ol und von dem entsprechenden halid acid. | |
| KR840000556A (ko) | 5,6,7,7a-테트라하이드로-4H-티에노(3,2-c)-피리딘-2-온 유도체의 제조방법 | |
| ES8602786A1 (es) | Derivados de pirimidoisoquinolina | |
| GB1363758A (en) | Process for the production of 1,2,4-oxa-diazoles and novel 1,2,4- oxadiazoles | |
| ES444036A1 (es) | Procedimiento de preparacion de la (tienil-2)-2-etilamina y sus derivados. | |
| ES8207179A1 (es) | Nuevo procedimiento de fabricacion de derivados de 5,6,7,7atetrahidro-4h-tieno(3,2-c)piridin-2-ona . | |
| ES8600188A1 (es) | Procedimiento de preparacion de un derivado 1,1-difenilpropan-1-ol | |
| DK566181A (da) | Fremgangsmaade til fremstilling af n-pyrrolylpyridazinaminderivater | |
| ES434406A1 (es) | Procedimiento para preparar derivados de naftiridina. | |
| ES444644A1 (es) | Un procedimiento de preparacion de derivados de la tienopi- ridina. | |
| ES450586A1 (es) | Procedimiento para preparar 1-azidoalquilimidazoles. | |
| FI863897L (fi) | Kemiskt foerfarande. | |
| GB1512168A (en) | Process for preparing 1-(beta-cyanoethylamino)-3-acylaminobenzenes | |
| ES8202345A1 (es) | Procedimiento para la obtencion de 7-oxabiciclo(2.2.1)-hept-5-en-dicarboximidas |